Cargando…

Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease

Peripheral artery disease (PAD) is a major cause of acute and chronic illness, with extremely poor prognosis that remains underdiagnosed and undertreated. Trimethylamine-N-Oxide (TMAO), a gut derived metabolite, has been associated with atherosclerotic burden. We determined plasma levels of TMAO by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roncal, Carmen, Martínez-Aguilar, Esther, Orbe, Josune, Ravassa, Susana, Fernandez-Montero, Alejandro, Saenz-Pipaon, Goren, Ugarte, Ana, Estella-Hermoso de Mendoza, Ander, Rodriguez, Jose A., Fernández-Alonso, Sebastián, Fernández-Alonso, Leopoldo, Oyarzabal, Julen, Paramo, Jose A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821861/ https://www.ncbi.nlm.nih.gov/pubmed/31666590 http://dx.doi.org/10.1038/s41598-019-52082-z

Ejemplares similares

The Role of Circulating Biomarkers in Peripheral Arterial Disease
por: Saenz-Pipaon, Goren, et al.
Publicado: (2021)

Hemostatic Biomarkers and Volumetry Help to Identify High-Risk Abdominal Aortic Aneurysms
por: Fernandez-Alonso, Sebastian, et al.
Publicado: (2022)

Urinary Extracellular Vesicles for Diabetic Kidney Disease Diagnosis
por: Saenz-Pipaon, Goren, et al.
Publicado: (2021)

Functional and transcriptomic analysis of extracellular vesicles identifies calprotectin as a new prognostic marker in peripheral arterial disease (PAD)
por: Saenz-Pipaon, Goren, et al.
Publicado: (2020)

Trimethylamine N-oxide (TMAO) in human health
por: Gatarek, Paulina, et al.
Publicado: (2021)

CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage
por: Navarro-Oviedo, Manuel, et al.
Publicado: (2022)

Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients
por: Hai, Xin, et al.
Publicado: (2015)

CM352 Reduces Brain Damage and Improves Functional Recovery in a Rat Model of Intracerebral Hemorrhage
por: Rodríguez, José A., et al.
Publicado: (2017)

Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine N-Oxide (TMAO) by Liquid Chromatography–Mass Spectrometry
por: Jia, Xun, et al.
Publicado: (2020)

Association of Urinary and Plasma Levels of Trimethylamine N-Oxide (TMAO) with Foods
por: Lombardo, Mauro, et al.
Publicado: (2021)

Association of the Chronotype Score with Circulating Trimethylamine N-Oxide (TMAO) Concentrations
por: Barrea, Luigi, et al.
Publicado: (2021)

Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
por: Constantino-Jonapa, Luis A., et al.
Publicado: (2023)

Association of SDF1 and MMP12 with Atherosclerosis and Inflammation: Clinical and Experimental Study
por: Marcos-Jubilar, María, et al.
Publicado: (2021)

Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
por: Randrianarisoa, Elko, et al.
Publicado: (2016)

Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism
por: Ding, Lin, et al.
Publicado: (2018)

Trimethylamine n-Oxide (TMAO) Modulates the Expression of Cardiovascular Disease-Related microRNAs and Their Targets
por: Díez-Ricote, Laura, et al.
Publicado: (2021)

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
por: Chen, Ming-liang, et al.
Publicado: (2016)

Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target
por: Janeiro, Manuel H., et al.
Publicado: (2018)

Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
por: Barrea, Luigi, et al.
Publicado: (2018)

2297 The direct effect of trimethylamine N-oxide (TMAO) on cardiac muscle contractile mechanics
por: Oakley, Carlee I., et al.
Publicado: (2018)

Neighborhood Environment Associates with Trimethylamine-N-Oxide (TMAO) as a Cardiovascular Risk Marker
por: Farmer, Nicole, et al.
Publicado: (2021)

Trimethylamine N-oxide (TMAO) Is not Associated with Cardiometabolic Phenotypes and Inflammatory Markers in Children and Adults
por: Andraos, Stephanie, et al.
Publicado: (2020)

Association of Trimethylamine N-Oxide (TMAO) with the Clinical Severity of Hidradenitis Suppurativa (Acne Inversa)
por: Barrea, Luigi, et al.
Publicado: (2021)

Trimethylamine N-Oxide (TMAO) and Indoxyl Sulfate Concentrations in Patients with Alcohol Use Disorder
por: Coulbault, Laurent, et al.
Publicado: (2022)

Trimethylamine N-oxide (TMAO) in patients with subarachnoid hemorrhage: a prospective observational study
por: Emonds, Julian Josef, et al.
Publicado: (2023)

Integrating Soluble Biomarkers and Imaging Technologies in the Identification of Vulnerable Atherosclerotic Patients
por: Páramo, José A., et al.
Publicado: (2007)

Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis
por: Chen, Lu, et al.
Publicado: (2020)

Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
por: Almesned, Mohammad A., et al.
Publicado: (2021)

Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective Compounds
por: Ilyas, Ashal, et al.
Publicado: (2022)

Probiotic Therapy to Attenuate Weight Gain and Trimethylamine N-oxide (TMAO) Generation: A Cautionary Tale
por: Tang, W. H. Wilson, et al.
Publicado: (2015)

Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide
por: Savi, Monia, et al.
Publicado: (2018)

A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO)
por: Barrea, Luigi, et al.
Publicado: (2019)

Matrix Metalloproteinases in Diabetic Kidney Disease
por: Garcia-Fernandez, Nuria, et al.
Publicado: (2020)

Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases
por: Martin-Ventura, Jose Luis, et al.
Publicado: (2022)

Marked elevation in plasma trimethylamine-N-oxide (TMAO) in patients with mitochondrial disorders treated with oral l-carnitine
por: Vallance, H.D., et al.
Publicado: (2018)

Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO)
por: Gessner, A., et al.
Publicado: (2018)

Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor
por: Lakshmi, G. B. V. S., et al.
Publicado: (2021)

Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics
por: Shanmugham, Meyammai, et al.
Publicado: (2023)

Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance
por: DiNicolantonio, James J, et al.
Publicado: (2019)

Protein Intake at Twice the RDA in Older Men Increases Circulatory Concentrations of the Microbiome Metabolite Trimethylamine-N-Oxide (TMAO)
por: Mitchell, Sarah M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2us53rej550mohpi1drkfa0lq0